| Compound | cimiracemoside G |
| NPACT-Id | NPACT01172 |
| IUPAC | - |
| Synonyms | - |
| PubChem Id | 21606552 |
| Class | Terpenoids |
| In-vitro anticancer activity | 1 cancer cell lines |
| In-Vivo anticancer activity | No |
| Targets | No targets found |
| Properties | Physical Elemental Topological |
| InChi Key | IHMRHYCBRKQAFU-LVQFCLPFSA-N |
| InChi | 1S/C37H56O11/c1-17-25-20(47-37(43)28(17)48-32(5,6)30(37)42)13-33(7)22-10-9-21-31(3,4)23(46-29-27(41)26(40)19(39)15-44-29)11-12-35(21)16-36(22,35)14-24(34(25,33)8)45-18(2)38/h10,17,19-21,23-30,39-43H,9,11-16H2,1-8H3/t17-,19-,20-,21-,23-,24+,25-,26-,27+,28+ |
| SMILES | O([C@H]1[C@]2([C@](C3=CC[C@@H]4[C@@]5([C@]3(C5)C1)CC[C@H](O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O)C4(C)C)(C[C@@H]1O[C@@]3(O)[C@H](OC([C@H]3O)(C)C)[C@H]([C@H]21)C)C)C)C(=O)C |
|
SMART | [H]O[C@@]1([H])[C@@]2(O[H])O[C@@]3([H])C([H])([H])[C@]4(C5=C([H])C([H])([H])[C@]6([H])[C@]7(C([H])([H])[C@@]57C([H])([H])[C@@]([H])(OC(=O)C([H])([H])[H])[C@]4(C([H])([H])[H])[C@@]3([H])[C@]([H])(C([H])([H])[H])[C@@]2([H])O[C@]1(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])[C@]([H])(O[C@]1([H])OC([H])([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H])[C@]6(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] |
| CAS No. | - |
|
Structure
Download | 
|
| Cross Refrence in other databases |
| Super Natural | - |
| CTD | - |
| HIT | - |
| NCI-60 GI50 data | - |
| Suppliers | NA, |
| Drug-Likeliness Filters | Lipinski's rule of five | No |
| Ghose filter | No |
| Veber filter | No |
| Muegge Filter | No |
| Similarity Search | Human metabolite database | FDA approved drugs |